These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31273159)

  • 21. Patient-reported outcome (PRO) questionnaires for men who have radical surgery for prostate cancer: a conceptual review of existing instruments.
    Protopapa E; van der Meulen J; Moore CM; Smith SC
    BJU Int; 2017 Oct; 120(4):468-481. PubMed ID: 28437031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deriving a compound quality of life measure from the EORTC-QLQ-C30/LC13 instrument for use in economic evaluations of lung cancer clinical trials.
    Bagust A; Barraza-Llorens M; Philips Z
    Eur J Cancer; 2001 Jun; 37(9):1081-8. PubMed ID: 11378337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRO-ONKO-selection of patient-reported outcome assessments for the clinical use in cancer patients-a mixed-method multicenter cross-sectional exploratory study.
    Schmidt H; Merkel D; Koehler M; Flechtner HH; Sigle J; Klinge B; Jordan K; Vordermark D; Landenberger M; Jahn P
    Support Care Cancer; 2016 Jun; 24(6):2503-12. PubMed ID: 26676238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its development.
    Koller M; Warncke S; Hjermstad MJ; Arraras J; Pompili C; Harle A; Johnson CD; Chie WC; Schulz C; Zeman F; van Meerbeeck JP; Kuliś D; Bottomley A; ;
    Cancer; 2015 Dec; 121(24):4300-23. PubMed ID: 26451520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of patient-reported outcomes in advanced breast cancer clinical trials: a review of the published literature.
    Turner-Bowker DM; Hao Y; Foley C; Galipeau N; Mazar I; Krohe M; Globe D; Shields AL
    Curr Med Res Opin; 2016 Oct; 32(10):1709-17. PubMed ID: 27331272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life.
    Fitzsimmons D; Johnson CD; George S; Payne S; Sandberg AA; Bassi C; Beger HG; Birk D; Büchler MW; Dervenis C; Fernandez Cruz L; Friess H; Grahm AL; Jeekel J; Laugier R; Meyer D; Singer MW; Tihanyi T
    Eur J Cancer; 1999 Jun; 35(6):939-41. PubMed ID: 10533475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
    Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
    J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life of lung cancer patients: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13.
    Chie WC; Yang CH; Hsu C; Yang PC
    Qual Life Res; 2004 Feb; 13(1):257-62. PubMed ID: 15058806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review of questionnaires to measure the impact of appearance on quality of life for head and neck cancer patients.
    Djan R; Penington A
    J Plast Reconstr Aesthet Surg; 2013 May; 66(5):647-59. PubMed ID: 23394687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EORTC QLQ-C30 summary score reliably detects changes in QoL three months after anatomic lung resection for Non-Small Cell Lung Cancer (NSCLC).
    Pompili C; Koller M; Velikova G; Franks K; Absolom K; Callister M; Robson J; Imperatori A; Brunelli A
    Lung Cancer; 2018 Sep; 123():149-154. PubMed ID: 30089587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer.
    Si X; Zhang L; Wang H; Zhang X; Wang M; Han B; Li K; Wang Q; Shi J; Wang Z; Cheng Y; He J; Shi Y; Chen W; Wang X; Luo Y; Nan K; Jin F; Li B; Chen Y; Zhou J; Wang D
    Lung Cancer; 2018 Aug; 122():32-37. PubMed ID: 30032842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electronic real-time assessment of patient-reported outcomes in routine care-first findings and experiences from the implementation in a comprehensive cancer center.
    Trautmann F; Hentschel L; Hornemann B; Rentsch A; Baumann M; Ehninger G; Schmitt J; Schuler M
    Support Care Cancer; 2016 Jul; 24(7):3047-56. PubMed ID: 26887586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective external convergence evaluation of two different quality-of-life instruments in lung resection patients.
    Pompili C; Brunelli A; Xiumé F; Refai M; Salati M; Socci L; Di Nunzio L; Sabbatini A
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):99-105. PubMed ID: 21159520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications.
    Stefanovic S; Wallwiener M; Karic U; Domschke C; Katic L; Taran FA; Pesic A; Hartkopf A; Hadji P; Teufel M; Schuetz F; Sohn C; Fasching P; Schneeweiss A; Brucker S
    Support Care Cancer; 2017 Feb; 25(2):549-558. PubMed ID: 27747478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer.
    King MT; Stockler MR; O'Connell RL; Buizen L; Joly F; Lanceley A; Hilpert F; Okamoto A; Aotani E; Bryce J; Donnellan P; Oza A; Avall-Lundqvist E; Berek JS; Sehouli J; Feeney A; Berton-Rigaud D; Costa DSJ; Friedlander ML;
    Qual Life Res; 2018 Jan; 27(1):59-74. PubMed ID: 29248998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age-related differences in patient-reported outcomes in patients with advanced lung cancer receiving anti-PD-1/PD-L1 therapy.
    King-Kallimanis BL; Kanapuru B; Blumenthal GM; Theoret MR; Kluetz PG
    Semin Oncol; 2018 Aug; 45(4):201-209. PubMed ID: 30482633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association of liver function and quality of life of patients with liver cancer.
    Li L; Mo F; Hui EP; Chan SL; Koh J; Tang NLS; Yu SCH; Yeo W
    BMC Gastroenterol; 2019 May; 19(1):66. PubMed ID: 31046687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reproducibility of the Brazilian Portuguese version of the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire used in conjunction with its lung cancer-specific module.
    Franceschini J; Jardim JR; Fernandes AL; Jamnik S; Santoro IL
    J Bras Pneumol; 2010; 36(5):595-602. PubMed ID: 21085825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Comparing Afatinib with Chemotherapy (LUX-Lung 3 and LUX-Lung 6).
    Wu YL; Hirsh V; Sequist LV; Hu CP; Feng J; Lu S; Huang Y; Schuler M; Mok T; Yamamoto N; O'Byrne K; Geater SL; Zhou C; Massey D; Märten A; Lungershausen J; Yang JC
    Patient; 2018 Feb; 11(1):131-141. PubMed ID: 29178024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.